Literature DB >> 32730877

Aucklandia costus (Syn. Saussurea costus): Ethnopharmacology of an endangered medicinal plant of the himalayan region.

Rohit Kumar Nadda1, Aaliya Ali2, Renu Chib Goyal3, Prem Kumar Khosla1, Rohit Goyal4.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Aucklandia costus Falc. a medicinal plant is native to the Himalayan region and synonymous with Saussurea costus, Saussurea lappa, and Aucklandia lappa. It has an ancient background of being used ethnopharmacologically for various body ailments. According to Ayurveda, Unani, Siddha, and Traditional Chinese Medicine, Costus roots are recommended for leukoderma, liver, kidney, blood disorders, Qi stagnation, and tridosha. Root and powder are used orally with warm water to cure gastric problems, and the paste is applied to the inflamed area to relieve pain. Root paste is applied on the skin to cure boils, blisters, and leprosy. AIM OF THE STUDY: The aim of the present review is to establish a correlation among the ethnopharmacological uses and scientific studies conducted on A. costus with chemical constituents, safety & toxicity data including future directions for its conservation with higher yield and effect.
MATERIALS AND METHODS: The study was conducted by studying books, research papers, and literature in history, agroforestry, phytopharmacology of Himalayan plants using international databases, publication, Red data book, and reports. The search engines: Pubmed, Scopus, Wiley Inter-science, Indian Materia Medica, Science Direct, and referred journals are referenced.
RESULTS: The literature collected from databases, journals, websites, and books mentioned the use of costus roots in local and traditional practices. CITES included A. costus in a critically endangered category due to lack of cultural practices and overexploitation from wild. A. costus roots are known since 13th century for use in ancient Ayurvedic products but the scientific evaluation is of future research interest. A correlation of traditional uses with scientific studies has been explored to assess the effect of root powder, extract, oil and isolated constituents: Costunolids, Saussureamine B and Dehydrocostus lactone etc. in gastric ulceration and lesions; inhibition of antigen-induced degranulation, mucin production, number of immune cells, eosinophils, and expression and secretion of Th2 cytokines (IL-4 and IL-13) in asthma. The inhibition of pro-inflammatory mediators is also reported by Cynaropicrin, Alantolactone, Caryophyllene, Costic acid. Also, the sesquiterpene lactones has profound effect in inhibition of inflammatory stages and induced apoptotic cascades in cancer. Very few data on the safety and toxicity of plant parts have been noted which needs to be evaluated scientifically.
CONCLUSION: A. costus have been noted to have remarkable effect for gastric, hepatic, inflammatory, respiratory, cancer, skin problems but there were several errors in selection of plant material, authentification, selection of dose, assessment, selection of standard and control have been identified. Therefore, a schematic drug development and research strategy exploiting the potential of plant extract, fraction, products and probable constituents, costunolide, dehydrocostus lactone, cynaropicrin, saussureamine assuring dose-response relationship and safety may be determined under pre-clinical which may be extrapolated to clinical level. An evaluation of phytochemicals in A. costus collected from different geographical location in Himalayas may be drawn to identify and conserve the higher yielding plant.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aucklandia; Conservation; Critically endangered; Ethnopharmacology; Himalayan; Saussurea

Year:  2020        PMID: 32730877     DOI: 10.1016/j.jep.2020.113199

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  7 in total

Review 1.  Back to the Roots-An Overview of the Chemical Composition and Bioactivity of Selected Root-Essential Oils.

Authors:  Karin Lunz; Iris Stappen
Journal:  Molecules       Date:  2021-05-25       Impact factor: 4.411

2.  The complete mitochondrial genome of Aucklandia lappa Decne. (Asteraceae, Aucklandia Falc.).

Authors:  Yue-Yue Song; Ting-Ting Zhang; Hui Tang; Liang Xu; Yan-Ping Xing; Rong Zhao; Gui-Hua Bao; Sheng-Nan Li; Da-Chuan Zhang; Yang Qiao; Yan-Yun Yang; Wu-Liji Ao; Ting-Guo Kang
Journal:  Mitochondrial DNA B Resour       Date:  2021-05-19       Impact factor: 0.658

Review 3.  Alantolactone: A Natural Plant Extract as a Potential Therapeutic Agent for Cancer.

Authors:  Yuan Cai; Kewa Gao; Bi Peng; Zhijie Xu; Jinwu Peng; Juanni Li; Xi Chen; Shuangshuang Zeng; Kuan Hu; Yuanliang Yan
Journal:  Front Pharmacol       Date:  2021-11-26       Impact factor: 5.810

Review 4.  The ethnomedicinal evidences pertaining to traditional medicinal herbs used in the treatment of respiratory illnesses and disorders in Saudi Arabia: A review.

Authors:  Hamad Ghaleb Dailah
Journal:  Saudi J Biol Sci       Date:  2022-07-22       Impact factor: 4.052

5.  Phytochemical Discrimination, Biological Activity and Molecular Docking of Water-Soluble Inhibitors from Saussurea costus Herb against Main Protease of SARS-CoV-2.

Authors:  Hajo Idriss; Babeker Siddig; Pamela González Maldonado; H M Elkhair; A I Alakhras; Emad M Abdallah; Pablo Hernán Sotelo Torres; Amin O Elzupir
Journal:  Molecules       Date:  2022-08-01       Impact factor: 4.927

6.  Exploring the Antifungal Activity and Action of Saussurea costus Root Extracts against Candida albicans and Non-albicans Species.

Authors:  Melad F Soliman; Youssria M Shetaia; Ahmed A Tayel; Alaa M Munshi; Fuad A Alatawi; Mohammed A Alsieni; Mahmoud A Al-Saman
Journal:  Antibiotics (Basel)       Date:  2022-03-01

7.  Dehydrocostus Lactone Suppresses Dextran Sulfate Sodium-Induced Colitis by Targeting the IKKα/β-NF-κB and Keap1-Nrf2 Signalling Pathways.

Authors:  Yun Yuan; Qiongying Hu; Lu Liu; Fan Xie; Luyao Yang; Yuchen Li; Chuantao Zhang; Hongqing Chen; Jianyuan Tang; Xiaofei Shen
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.